NMN (Nicotinamide Mononucleotide) vs Urolithin A

A side-by-side comparison from PeptideSciences101, the open peptide reference.

Overview

NMN (Nicotinamide Mononucleotide) is primarily a anti-aging & longevity peptide, while Urolithin A is used for anti-aging & longevity.

This page compares NMN (Nicotinamide Mononucleotide) and Urolithin A across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.

Side-by-side comparison

NMN (Nicotinamide Mononucleotide)Urolithin A
CategoryAnti-aging & LongevityAnti-aging & Longevity
Regulatory status (US)Research use onlyResearch use only
Typical dosage250-500 mg250-500 mg
FrequencyDaily oral or subQdaily
Reported benefitsNAD+ repletion, mitochondrial biogenesis, sirtuin activation, DNA repair.Mitochondrial health, muscle function, longevity
Reported side effectsGenerally well-tolerated; rare GI discomfort.Well-tolerated

Key differences

Primary use. NMN (Nicotinamide Mononucleotide) is categorised under Anti-aging & Longevity, while Urolithin A falls under Anti-aging & Longevity. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.

Regulatory status. NMN (Nicotinamide Mononucleotide): not FDA-approved; treated as a research compound. Urolithin A: not FDA-approved; treated as a research compound.

Dosing. NMN (Nicotinamide Mononucleotide) is typically dosed at 250-500 mg (Daily oral or subQ). Urolithin A is typically dosed at 250-500 mg (daily).

Can you stack them?

Some protocols combine peptides, but stacking NMN (Nicotinamide Mononucleotide) and Urolithin A has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.

Frequently asked questions

What is the difference between NMN (Nicotinamide Mononucleotide) and Urolithin A?
NMN (Nicotinamide Mononucleotide) is primarily a anti-aging & longevity peptide, while Urolithin A is used for anti-aging & longevity. NMN (Nicotinamide Mononucleotide) is not FDA-approved; generally classified as a research compound, whereas Urolithin A is not FDA-approved; generally classified as a research compound.
What is NMN (Nicotinamide Mononucleotide) used for?
NAD+ direct precursor nucleotide; key longevity compound.
What is Urolithin A used for?
Mitochondrial health compound.
Can you take NMN (Nicotinamide Mononucleotide) and Urolithin A together?
Some users combine peptides within a single protocol, but stacking NMN (Nicotinamide Mononucleotide) and Urolithin A has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
Is NMN (Nicotinamide Mononucleotide) or Urolithin A FDA-approved?
NMN (Nicotinamide Mononucleotide) is not FDA-approved; generally classified as a research compound. Urolithin A is not FDA-approved; generally classified as a research compound.

Read the full articles

← All peptide comparisons